Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Micron Technology
MU
$1.02T
| $20.8M | 0.03% |
503,123
-1,232,324
| -71% | -$47.6M |
|
777
Lam Research
LRCX
$365B
| $20.8M | 0.03% |
1,159,260
+747,520
| +182% | +$12.5M |
|
778
BOK Financial
BOKF
$8.58B
| $20.7M | 0.03% |
254,262
+179,332
| +239% | +$15.1M |
|
779
American International
AIG
$42B
| $20.7M | 0.03% |
481,255
+192,424
| +67% | +$8.23M |
|
780
Helix Energy Solutions
HLX
$1.42B
| $20.6M | 0.03% |
2,603,190
-844,867
| -25% | -$6.05M |
|
|
781
CALL
Walt Disney
DIS
$168B
| $20.6M | 0.03% |
185,400
+169,800
| +1,088% | +$19M |
|
782
Penumbra
PEN
$12.6B
| $20.6M | 0.03% |
139,902
-34,771
| -20% | -$4.97M |
|
783
Usana Health Sciences
USNA
$412M
| $20.5M | 0.03% |
244,610
+130,657
| +115% | +$13.6M |
|
784
Veracyte
VCYT
$4.44B
| $20.5M | 0.03% |
819,227
-599,059
| -42% | -$11.4M |
|
785
PUT
Salesforce
CRM
$142B
| $20.5M | 0.03% |
129,400
+70,400
| +119% | +$10.9M |
|
786
Schneider National
SNDR
$6.44B
| $20.5M | 0.03% |
972,391
-417,310
| -30% | -$8.93M |
|
787
Cheniere Energy
LNG
$53.6B
| $20.5M | 0.03% |
299,402
-1,425,869
| -83% | -$93.7M |
|
788
Olin
OLN
$2.49B
| $20.3M | 0.03% |
879,228
-1,606,181
| -65% | -$38.4M |
|
789
PTC Therapeutics
PTCT
$6.29B
| $20.3M | 0.03% |
538,001
+374,690
| +229% | +$12.6M |
|
790
Hanover Insurance
THG
$7.68B
| $20.2M | 0.03% |
177,241
-11,259
| -6% | -$1.3M |
|
791
Cigna
CI
$77B
| $20.1M | 0.03% |
125,281
-504,457
| -80% | -$92.1M |
|
792
PENN Entertainment
PENN
$2.83B
| $20.1M | 0.03% |
1,001,667
+883,171
| +745% | +$20.7M |
|
793
Rayonier
RYN
$6.52B
| $20.1M | 0.03% |
703,442
+159,016
| +29% | +$4.24M |
|
794
CALL
Novartis
NVS
$297B
| $20.1M | 0.03% |
+232,909
| New | +$18.7M |
|
795
Bank of Hawaii
BOH
$3.17B
| $20M | 0.03% |
253,720
+187,482
| +283% | +$14.7M |
|
|
DHR.PRA
796
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $19.9M | 0.03% |
+18,963
| New | +$19.6M |
|
797
Brunswick
BC
$5.24B
| $19.9M | 0.03% |
395,927
+325,861
| +465% | +$16.4M |
|
798
PUT
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
| $19.8M | 0.03% |
+600,000
| New | +$19.3M |
|
799
Pacific Biosciences
PACB
$422M
| $19.7M | 0.03% |
2,730,462
+64,374
| +2% | +$466K |
|
800
Fair Isaac
FICO
$29.7B
| $19.7M | 0.03% |
72,433
-90,027
| -55% | -$21.2M |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.